Eight first cheques. Top decile globally.
Three out of every four companies still active. The harvest has just begun.
Boson Newton Fund II
Fund I is in harvest. Newton II is deploying first cheques into Australian deep tech — bio & medical, advanced manufacturing, AI & robotics. Top-decile Fund I track record. ESVCLP. 10% tax offset + CGT exemption.
Six conviction positions.
Five of eight are above 3.5× MOIC; two write-offs are below 2021-vintage norms.

Osara Health
Osara Health 是一家澳洲数字健康成长型公司,专注于为癌症患者及照护者提供循证、个性化的健康支持与行为干预服务。
Hello Clever
Hello Clever 是一家金融科技公司,致力于实现即时银行到账支付,绕开传统银行卡支付手续费,同时在支付环节提供现金返还和奖励机制。可以被理解为一个面向商户和零售场景的下一代 PayID 支付解决方案。它解决的是澳大利亚商户长期面临的两个真实痛点:信用卡手续费高,以及资金结算速度慢。
Fiable
Fiable is an Australian fintech company delivering a digital financial viability platform for the construction, property, civil, utilities, and government sectors. The platform enables organisations to rapidly assess the financial health of suppliers, subcontractors, and vendors — reducing insolvency risk, improving supply chain transparency, and supporting more informed procurement decisions.

Kite Magnetics
Kite Magnetics is an Australian deep-tech company revolutionising electric mobility through advanced magnetic materials. Founded in 2021 as a spinout from Monash University, the company has developed Aeroperm® — a proprietary nanocrystalline magnetic material that reduces electric motor core losses by up to 97%, without relying on rare-earth supply chains. By directly replacing conventional electrical steel in motor stator cores, Aeroperm® enables electric vehicles, aerospace platforms, and industrial motors to travel further, carry more, and cost less to manufacture. Headquartered in Melbourne, Victoria, and backed by global investors including SQM Lithium Ventures, Breakthrough Victoria, and Boson Ventures, Kite Magnetics is scaling from laboratory breakthrough to pilot production — delivering a critical solution for the future of clean, efficient energy.
Catalyser
Catalyser is a certified B Corporation and leading social enterprise headquartered in Sydney, Australia. Founded in 2015 by Angela Kwan and Aivee Robinson, the company operates a modular, white-label SaaS platform that enables corporations to manage all aspects of their ESG and CSR programs — from payroll giving and volunteering to fundraising, pro bono work, and impact reporting. With access to over 25,000 charities across 30+ countries and a community of 90,000+ donors, Catalyser empowers businesses to build a meaningful culture of giving at scale. Its newest platform, Catalyser Inspire, delivers real-time impact analytics, donation matching optimisation, and AI-powered volunteer matching — setting a new standard for corporate social impact management across the Asia-Pacific region.

AI-NC
AI-NC 是一家澳洲 AI + 先进制造 B2B SaaS 公司,利用人工智能优化工程设计与 CNC 制造流程,帮助硬件产品更快从设计走向生产。

Storipress
面向独立媒体的现代出版平台。2024 年在业务转型未达到产品市场契合后停止运营。依 IPEV 标准以 0× 计。

Loop+
面向残障人士的数字医疗平台。2024 年停止运营。依 IPEV 标准以 0× 计。
Kite Magnetics — Monash bench to 5.0× in four years.
Sourced from Monash before IP-assignment. Independent DD by Tokyo Tech and Tsinghua University. Boson facilitated intros to EHang and Zero Gravity. SQM led the Seed+ round.
“Boson has been very stuck with us from day one — not just capital, but very critical insight in China market.”
— Richard Parsons, CEO & Founder, Kite Magnetics
Honest about losses.
Two of eight Fund I positions did not make it. Reported at 0× — below 2021-vintage industry norms.
Two biotech breakouts, backed by our GP.
Personal-track biotech investments made by Boson’s founding partner. Separate from Fund I economics, same conviction thesis — platform science with global reach.

明晰制药
Clarity Pharmaceuticals 是一家处于临床阶段的放射性药物公司,专注于开发面向肿瘤领域的新一代诊疗一体化产品,即同时用于治疗和影像诊断的产品。公司基于其专有的 SAR Technology 平台进行产品开发。其 Targeted Copper Theranostic(TCT,靶向铜诊疗一体化)平台采用铜-64用于影像诊断、铜-67用于治疗的配对模式,以提升多种癌症治疗中的准确性与精准度。公司的临床开发管线包括 SAR-bisPSMA、SAR-Bombesin 和 SARTATE,覆盖的适应症包括前列腺癌、乳腺癌、神经内分泌肿瘤以及神经母细胞瘤。

Junshi Bio
Building in Australian deep tech?
We back founders before the world catches on. First cheque, science-led DD, China corridor.
Apply for funding →